NCT02052427View on ClinicalTrials.gov

Safety & Efficacy of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia (ATHENA II)

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

October 31, 2016

Conditions
Myocardial Ischemia
Interventions
DEVICE

Celution System

ADRCs processed by the Celution System for reintroduction into the myocardium

DEVICE

Placebo

Physiological solution made of Lactated Ringers solution and a small amount (\<1mL) of autologous blood

Trial Locations (1)

11100

University Hospital Case Medical Center, Cleveland

Sponsors
All Listed Sponsors
lead

Cytori Therapeutics

INDUSTRY